Blair Jackson shares his thoughts on Alkermes' past and future as a neuroscience company.
Hear from Steve Schiavo on Alkermes' dedication to supporting employees as they care for loved ones.
Hear from Craig Hopkinson, M.D. as he reflects on the unmet needs of people living with narcolepsy.
Alkermes leverages its deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. As a fully-integrated, global biopharmaceutical company, with U.S. locations in Massachusetts and Ohio, and locations in Dublin and Athlone, Ireland, we seek to make a meaningful difference in the way people manage their diseases. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized.